Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

By Yang Lingyun   Li Ningwei   Wang Hongjing   Jia Xibiao   Wang Xue   Luo Juan  

Oncology Reports, Vol. 28, Iss. 2, 2012-08 ,pp. : 592-600

Spandidos Publications

Access to resources Recommend Favorite

NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis

By      

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 188-196

Spandidos Publications

Access to resources Recommend Favorite

A germline mutation in the miR125a coding region reduces miR125a expression and is associated with human gastric cancer

By          

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1839-1844

Spandidos Publications

Access to resources Recommend Favorite

miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1

By Zhou Li   Qiu Tianzhu   Xu Jing   Wang Tongshan   Wang Jian   Zhou Xin   Huang Zebo   Zhu Wei   Shu Yongqian   Liu Ping  

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

Enforced expression of miR101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase2 pathway

By          

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2203-2209

Spandidos Publications

Access to resources Recommend Favorite